Back to search results

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Negative Breast Carcinoma · Hormone Receptor-Positive Breast Carcinoma · Invasive Breast Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Grady Healthcare System, Atlanta, Georgia, United States

    Contact: Study coordinator (Obi Ezennia) · obichukwu.ezennia@emory.edu
    Contact: Principal Investigator (Ruth Sacks, MD)

  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Carlos E. Aguilera) · carlos.e.aguilera.zenteno@emory.edu · 404-778-4982
    Contact: Principal Investigator (Ruth L. Sacks, MD)

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Ashley Trumbull) · ashley.lynn.trumbull@emory.edu · 404-778-3969
    Contact: Principal Investigator (Ruth L. Sacks, MD)

  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Jody Ewing) · jody.ewing@emory.edu · 678-843-7029
    Contact: Principal Investigator (Ruth L. Sacks, MD)
Study leads

  • Ruth L. Sacks, MD

    Principal Investigator

    Emory University Hospital/Winship Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)